Skip to main content

Zura Bio Ltd

ZURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855644

No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Zura Bio Ltd changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of ZURA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders4557+12
Shares14.9M32.9M+18.0M (+121.0%)
Value$37.6M$114.9M+$77.3M (+205.7%)

New holders (18)

Institutions that held Zura Bio Ltd at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ZURA in Q2 2024
InstitutionSharesValue% of portfolio
VR Adviser, LLC6,023,166$21.1M1.34%
Ra Capital Management, L.P.3,217,503$11.3M0.15%
Point72 Asset Management, L.P.2,413,127$8.45M0.03%
Woodline Partners LP515,899$1.81M0.02%
Polar Asset Management Partners Inc.259,241$907.3K0.02%
Superstring Capital Management LP156,626$548.2K0.69%
UBS Oconnor LLC73,396$256.9K0.01%
Two Sigma Investments, LP51,737$181.1K0.00%
AQR Capital Management LLC12,319$43.1K0.00%
Mariner, LLC11,279$39.5K0.00%
Corebridge Financial, Inc.10,768$37.7K0.00%
Mirae Asset Global ETFs Holdings Ltd.8,135$28.5K0.00%
Royal Bank of Canada1,882$7.00K0.00%
Legal & General Group Plc1,906$6.67K0.00%
Russell Investments Group, Ltd.628$2.20K0.00%
CWM, LLC187$1.00K0.00%
SRS Capital Advisors, Inc.245$8580.00%
Nisa Investment Advisors, LLC6$210.00%

Sold out (6)

Institutions that held Zura Bio Ltd at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ZURA in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Meteora Capital, LLC28,702$73.8K
Invesco Ltd.21,456$55.1K
Calamos Advisors LLC200,000$54.0K
Occudo Quantitative Strategies LP19,042$48.9K
American International Group, Inc.8,396$21.6K
Impact Partnership Wealth, LLC6$15